[ad_1]
The US drug giant agrees to pay $ 230m to end what it says has sparked a deadly opioid epidemic.
U.S. Attorney General Johnson & Johnson has agreed to pay $ 230m to address the company’s contribution to the opioid crisis, New York’s attorney general said on Saturday.
Attorney General Letitia James said in a statement that “the opioid epidemic has devastated many people in New York State and the rest of the country, leaving millions of people still on dangerous and dangerous opioids.
“Johnson & Johnson helped ignite the fire, but today they are committed to stopping the opioid business – not only in New York, but throughout the country. Opioids will no longer be manufactured or sold in the United States by J&J,” James said.
“We are also donating up to $ 230 million to support opioid prevention, medical care, and education throughout New York.”
The deal includes a lawsuit filed by James in 2019 and the dismissal of Johnson & Johnson in a case that is due to begin next week on Long Island.
It’s part of murder on an estimated 500,000 deaths related to the last two decades.
“In the same way, to pay the full amount, [Johnson & Johnson] has withdrawn from an unprecedented case, ”Mike Hanna of Al Jazeera of Washington, DC. Hanna added that the upcoming case would be a court case – something that has never been done “in such cases”.
In a statement issued on Saturday, Johnson & Johnson denied the allegations. He also said that the establishment relates to two painkillers – manufactured by a support company and accounting for less than 1% of the market value – that have not been sold in the US before.
The adoption was not “acknowledging that the company has a problem or error”, says Johnson & Johnson. It further stated that his actions “related to the marketing and promotion of essential herbal remedies were appropriate and reliable”.
The company also said the trade was in line with their first $ 5bn agreement to end opioid claims by states, cities, regions and national governments across the country.
The U.S. drug company and drug distributors – AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp – have offered a $ 26bn package in addition to tackling thousands of opioid cases.
Opioid testing Tuesday is just one of several scheduled for this year, with some taking place in California and West Virginia.
West Virginia has the world’s highest risk of opioid overdose. The trend has skyrocketed since the early 2000s, when pharmaceutical manufacturers such as oxycodone and hydrocodone increased their sales through retail stores and doctors.
The U.S. Centers for Disease Control and Prevention estimates that some 500,000 people have died from opioid overdoses from 1999 to 2019.
[ad_2]
Source link
